FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCannara Biotech Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
LOVE.TO
Cannara Biotech Inc. Stock AnalysisComprehensive stock analysis for Cannara Biotech Inc. (LOVE.TO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLOVE.TO
LOVE.TO
Cannara Biotech Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
LOVE.TO
  1. Home
  2. Stocks
  3. Cannara Biotech Inc.

Cannara Biotech Inc.

🇨🇦LOVE.TO•TSX

Cannara Biotech Inc.

🇨🇦LOVE.TO•TSX
Market cap
$198.06M
P/E ratio
17.87

Your view on LOVE.TO

Mkt Cap
$198.06M
P/E
17.87
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cannara Biotech Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Zohar Krivorot
Headquarters
333 Decarie Blvd., Saint-Laurent, QC, CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Zohar Krivorot
Headquarters
333 Decarie Blvd., Saint-Laurent, QC, CA
Description

Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities.

Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Cannara Biotech Inc. from FRC's valuation model, read against the market price. LOVE.TO last traded at C$2.00, 17.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cannara Biotech Inc.. Starting points for Cannara Biotech Inc.: P/E 17.9, EPS C$0.11, beta 0.33 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cannara Biotech Inc.. Trailing twelve-month EPS for Cannara Biotech Inc. stands at C$0.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterAug 2026Next quarterNov 2026This yearYear to Aug 2026Next yearYear to Aug 2027
Average estimateCAD 0.04CAD 0.05CAD 0.12CAD 0.21
Lowest estimateCAD 0.04CAD 0.05CAD 0.12CAD 0.20
Highest estimateCAD 0.04CAD 0.05CAD 0.12CAD 0.23
Number of analysts1133
A year ago—CAD 0.01CAD 0.14—
Growth vs a year ago—+400.0%−14.3%—

Revenue estimates

TotalThis quarterAug 2026Next quarterNov 2026This yearYear to Aug 2026Next yearYear to Aug 2027
Average estimateCAD 34.55MCAD 35.48MCAD 123.38MCAD 145.97M
Lowest estimateCAD 33.11MCAD 34.11MCAD 122.19MCAD 142.48M
Highest estimateCAD 35.91MCAD 36.51MCAD 124.99MCAD 149.50M
Number of analysts3344
A year ago—CAD 30.11MCAD 107.32M—
Growth vs a year ago—+17.8%+15.0%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cannara Biotech Inc.. Cannara Biotech Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold LOVE.TO19 companies
Compare LOVE.TO with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
CRDL.TOCardiol Therapeutics Inc.HealthcareDrug Manufacturers - Specialty & Generic$164.1M
DB.VDecibel Cannabis Company Inc.HealthcareDrug Manufacturers - Specialty & Generic$54.4M
GRIN.CNGrown Rogue International Inc.HealthcareDrug Manufacturers - Specialty & Generic$149.7M
HBP.TOHelix BioPharma Corp.HealthcareBiotechnology$65.7M
HLS.TOHLS Therapeutics Inc.HealthcareDrug Manufacturers - Specialty & Generic$116.3M
JUSH.CNJushi Holdings Inc.HealthcareDrug Manufacturers - Specialty & Generic$165.2M
MSCL.TOSatellos Bioscience Inc.HealthcareBiotechnology$182.9M
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
VIVXFAvivagen Inc.HealthcareOTC$7,769
VLS.AXVita Life Sciences LimitedHealthcareASX—
VM.VVoyageur Pharmaceuticals Ltd.HealthcareTSXV$23.1M
VPHIFValeo Pharma Inc.HealthcareOTC$9,866
VREOFVireo Growth Inc.HealthcareOTC$502.5M
VRNOVerano Holdings Corp.HealthcareOTC$426.9M
VRNO.NEVerano Holdings Corp.HealthcareNEO—
VRTHFIndigenous Bloom Hemp Corp.HealthcareOTC$131,146
VTRSViatris Inc.HealthcareNASDAQ$23.3B
VYYRFVoyageur Pharmaceuticals Ltd.HealthcareOTC$22.5M
WEED.TOCanopy Growth CorporationHealthcareTSX$323.7M
WIBFFWest Island Brands Inc.HealthcareOTC$60,061
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cannara Biotech Inc.

LOVE.TO AnalysisGood
Past
3
Growth
5
Health
4
Profit
2
Value
2